Hirano body-rich subtypes of Creutzfeldt-Jakob disease

Neuropathology and Applied Neurobiology

Volumn 38, Issue 2, 2012, Pages 153-161

  Martinez Saez, E ^a,b   Gelpi, E ^a   Rey, M J ^a   Ferrer, I ^d   Ribalta, T ^b   Botta Orfila, T ^a,b   Nos, C ^c   Yague J ^b   Sanchez Valle, R ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c General Subdirectorate of Surveillance and Response to Emergencies in Public Health ^*  (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Creutzfeldt Jakob disease; Hirano bodies; Molecular subtypes; SCJD; VV1 subtype

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; FEMALE; GENE INSERTION; GENERAL PATHOLOGICAL PARAMETERS; GENOTYPE; HIPPOCAMPUS; HIRANO BODY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; WESTERN BLOTTING;

14-3-3 PROTEINS; ADULT; AGE FACTORS; AGED; BLOTTING, WESTERN; BRAIN; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; PRPSC PROTEINS;

EID: 84857882644     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2011.01208.x     Document Type: Article

References (26)

1. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-33
2. Parchi P, Strammiello R, Notari S, Giese A, Langeveld JP, Ladogana A, Zerr I, Roncaroli F, Cras P, Ghetti B, Pocchiari M, Kretzschmar H, Capellari S. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 2009; 118: 659-71
3. Meissner B, Westner IM, Kallenberg K, Krasnianski A, Bartl M, Varges D, Bösenberg C, Kretzschmar HA, Knauth M, Schulz-Schaeffer WJ, Zerr I. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 2005; 65: 1544-50
4. Cartier L, Gálvez S, Gajdusek DC. Familial clustering of the ataxic form of Creutzfeldt-Jakob disease with Hirano bodies. J Neurol Neurosurg Psychiatry 1985; 48: 234-8
5. Guiroy DC, Liberski PP, Williams ES, Gajdusek DC. Electron microscopic findings in brain of Rocky Mountain elk with chronic wasting disease. Folia Neuropathol 1994; 32: 171-3
6. Baloyannis SJ, Manolidis SL, Manolidis LS. Synaptic alterations in acoustic cortex in Creutzfeldt-Jacob disease. Acta Otolaryngol 1995; 115: 202-5
7. Hirano A. Hirano bodies and related neuronal inclusions. Neuropathol Appl Neurobiol 1994; 20: 3-11
8. Gibson PH, Tomlinson BE. Numbers of Hirano bodies in the hippocampus of normal and demented people with Alzheimer's disease. J Neurol Sci 1977; 33: 199-206
9. Kovacs GG, Budka H. Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases. Clin Neuropathol 2010; 29: 271-88
10. Dickson DW. Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases. Acta Neuropathol 2005; 109: 14-24
11. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006; 112: 389-404
12. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Neurology 1991; 41: 479-86
13. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211
14. Budka H. Histopathology and immunohistochemistry of human transmissible spongiform encephalopathies (TSEs). Arch Virol Suppl 2000; 16: 135-42
15. Sanchez-Valle R, Nos C, Yagüe J, Graus F, Dominguez A, Saiz A, Catalan Collaborative Study Group for CJD. Clinical and genetic features of human prion diseases in Catalonia: 1993-2002. Eur J Neurol 2004; 11: 649-55
16. Jordan-Sciutto K, Dragich J, Walcott D, Bowser R. The presence of FAC1 protein in Hirano bodies. Neuropathol Appl Neurobiol 1998; 24: 359-66
17. Ha S, Furukawa R, Fechheimer M. Association of AICD and Fe65 with Hirano bodies reduces transcriptional activation and initiation of apoptosis. Neurobiol Aging 2010; 2 February. doi: 10.1016/j.neurobiolaging.2010.01.003
18. Pamplona R, Naudí A, Gavín R, Pastrana MA, Sajnani G, Ilieva EV, Del Río JA, Portero-Otín M, Ferrer I, Requena JR. Increased oxidation, glycoxidation, and lipoxidation of brain proteins in prion disease. Free Radic Biol Med 2008; 45: 1159-66
19. Freixes M, Rodríguez A, Dalfó E, Ferrer I. Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease. Neurobiol Aging 2006; 27: 1807-15
20. Martin SF, Burón I, Espinosa JC, Castilla J, Villalba JM, Torres JM. Coenzyme Q and protein/lipid oxidation in a BSE-infected transgenic mouse model. Free Radic Biol Med 2007; 42: 1723-9
21. Santa-Maria I, Santpere G, MacDonald MJ, Gomez de Barreda E, Hernandez F, Moreno FJ, Ferrer I, Avila J. Coenzyme q induces tau aggregation, tau filaments, and Hirano bodies. J Neuropathol Exp Neurol 2008; 67: 428-34
22. Kim DH, Davis RC, Furukawa R, Fechheimer M. Autophagy contributes to degradation of Hirano bodies. Autophagy 2009; 5: 44-51
23. Worrall BB, Herman ST, Capellari S, Lynch T, Chin S, Gambetti P, Parchi P. Type 1 protease resistant prion protein and valine homozygosity at codon 129 of PRNP identify a subtype of sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1999; 67: 671-4
24. Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, Zerr I, Heinemann U, Kretszchmar HA, Jansen GH, Olsen E, Mitrova E, Alpérovitch A, Brandel JP, Mackenzie J, Murray K, Will RG. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006; 129: 2278-87
25. Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain 2007; 130: 1350-9
26. Tanev KS, Yilma M. An unusually presenting case of sCJD-the VV1 subtype. Clin Neurol Neurosurg 2009; 111: 282-91